Ivermectin for COVID-19: real-time meta analysis of 95 studies
95 ivermectin COVID-19 controlled studies. 82% improvement for prophylaxis, p < 0.0001. 62% improvement for early treatment, p < 0.0001. 42% improvement for late treatment, p < 0.0001. ivmmeta
About the WHO quote..."This appears to be based primarily on excluding the majority of the evidence, and by assigning bias estimates that do not match the actual risk of bias in studies."